# Healthfirst Bluegrass Inc.

Health Center, KY
Page: https://astrelis.co/providers/health_center/181812  
This twin: https://astrelis.co/providers/health_center/181812.md  
CMS Certification Number (CCN): 181812  
Release: 2321a4fc37a7 (2026-10-22)

## Headline figures (fiscal years on file: 2019 to 2025)

- **Total patients (UDS) (FY2024):** 25,466. Reported value. Definition: https://astrelis.co/methodology#health-center
- **Operating margin (FY2025):** -74.7%. Astrelis calculation. Definition: https://astrelis.co/methodology#health-center
- **Service sites (FY2024):** 22. Reported value. Definition: https://astrelis.co/methodology#health-center
- **Uninsured patient share (FY2024):** 29.6%. Illustrative estimate. Definition: https://astrelis.co/methodology#health-center
- **Total operating revenue (FY2025):** $18.0M. Reported value. Definition: https://astrelis.co/methodology#health-center
- **Total margin (including nonoperating) (FY2025):** -5.7%. Astrelis calculation. Definition: https://astrelis.co/methodology#health-center

## Audited financial statements (Federal Audit Clearinghouse)

Read from the FAC-11 template of the audited statements: every line, every ratio and every status column print as the template carries them, and no figure is withheld. A report's tie status says whether its statements foot; a ratio's plausibility status says whether it sits inside its possible range; a median of fewer than five values says so. The figures were not audited by Astrelis. Contract: https://astrelis.co/methodology/fqhc-audit-contract

### HEALTH FIRST BLUEGRASS, KY

Match to this profile: matched by name (method: name and state).

- FY ending 2025-12-31 (audit year 2025): ties in full; audit as filed https://app.fac.gov/dissemination/summary/2025-12-GSAFAC-0000418948
- FY ending 2024-12-31 (audit year 2024): ties in full; audit as filed https://app.fac.gov/dissemination/summary/2024-12-GSAFAC-0000370766
- FY ending 2023-12-31 (audit year 2023): ties in full; audit as filed https://app.fac.gov/dissemination/summary/2023-12-GSAFAC-0000042322

| Line | FY ending 2025-12-31 | FY ending 2024-12-31 | FY ending 2023-12-31 |
|---|---:|---:|---:|
| cash and investments (current) (Statement of financial position) | 13,993,864 [derived, p.6] | 15,798,290 [derived, p.6] | 16,081,779 [derived, p.6] |
| patient receivables, net (Statement of financial position) | 1,983,441 [derived, p.6] | 1,492,680 [derived, p.6] | 1,978,261 [derived, p.6] |
| grants and other receivables (Statement of financial position) | 188,633 [derived, p.6] | absent (not printed, or not read) | 67,328 [derived, p.6] |
| other current assets (Statement of financial position) | 845,456 [derived, p.6] | 810,441 [derived, p.6] | 700,331 [derived, p.6] |
| TOTAL CURRENT ASSETS (Statement of financial position) | 17,011,394 [extracted, p.6] | 18,101,411 [extracted, p.6] | 18,827,699 [extracted, p.6] |
| property and equipment, net (Statement of financial position) | 15,496,516 [derived, p.6] | 15,966,487 [derived, p.6] | 17,083,594 [derived, p.6] |
| other long-term assets (Statement of financial position) | 1,426,006 [derived, p.6] | 1,465,380 [derived, p.6] | 1,807,162 [derived, p.6] |
| TOTAL ASSETS (Statement of financial position) | 33,933,916 [extracted, p.6] | 35,533,278 [extracted, p.6] | 37,718,455 [extracted, p.6] |
| payables and accrued expenses (Statement of financial position) | 1,078,712 [derived, p.6] | 1,584,905 [derived, p.6] | 2,094,286 [derived, p.6] |
| deferred revenue (Statement of financial position) | absent (not printed, or not read) | absent (not printed, or not read) | absent (not printed, or not read) |
| current debt and leases (Statement of financial position) | 432,064 [derived, p.6] | 442,257 [derived, p.6] | 460,338 [derived, p.6] |
| other current liabilities (Statement of financial position) | 739,492 [derived, p.6] | absent (not printed, or not read) | absent (not printed, or not read) |
| TOTAL CURRENT LIABILITIES (Statement of financial position) | 2,250,268 [extracted, p.6] | 2,027,162 [extracted, p.6] | 2,554,624 [extracted, p.6] |
| long-term debt and leases (Statement of financial position) | 4,852,180 [derived, p.6] | 4,984,035 [derived, p.6] | 5,402,172 [derived, p.6] |
| other long-term liabilities (Statement of financial position) | absent (not printed, or not read) | absent (not printed, or not read) | absent (not printed, or not read) |
| TOTAL LIABILITIES (Statement of financial position) | 7,102,448 [extracted, p.6] | 7,011,197 [extracted, p.6] | 7,956,796 [extracted, p.6] |
| net assets without donor restrictions (Statement of financial position) | 26,831,468 [derived, p.6] | 28,522,081 [derived, p.6] | 29,761,659 [derived, p.6] |
| net assets with donor restrictions (Statement of financial position) | absent (not printed, or not read) | absent (not printed, or not read) | absent (not printed, or not read) |
| TOTAL NET ASSETS (Statement of financial position) | 26,831,468 [extracted, p.6] | 28,522,081 [extracted, p.6] | 29,761,659 [extracted, p.6] |
| patient service revenue, net (Statement of activities) | 17,998,317 [derived, p.7] | 21,120,051 [derived, p.7] | 17,996,668 [derived, p.7] |
| pharmacy and 340B revenue (Statement of activities) | 5,425,600 [derived, p.7] | 4,943,416 [derived, p.7] | 4,893,355 [derived, p.7] |
| federal grants (Statement of activities) | absent (not printed, or not read) | absent (not printed, or not read) | absent (not printed, or not read) |
| other grants and contracts (Statement of activities) | 4,064,362 [derived, p.7] | 3,831,461 [derived, p.7] | 7,307,341 [derived, p.7] |
| contributions (Statement of activities) | absent (not printed, or not read) | absent (not printed, or not read) | absent (not printed, or not read) |
| other revenue (Statement of activities) | 1,300,052 [derived, p.7] | 857,140 [derived, p.7] | 1,101,389 [derived, p.7] |
| TOTAL REVENUE AND SUPPORT (Statement of activities) | 28,788,331 [extracted, p.7] | 30,752,068 [extracted, p.7] | 31,298,753 [extracted, p.7] |
| salaries and benefits (Statement of activities) | 20,960,993 [derived, p.7] | 21,874,081 [derived, p.7] | 21,939,161 [derived, p.7] |
| supplies and pharmaceuticals (Statement of activities) | 4,146,586 [derived, p.7] | 4,429,373 [derived, p.7] | 5,090,870 [derived, p.7] |
| purchased and professional services (Statement of activities) | 3,847,017 [derived, p.7] | 4,011,683 [derived, p.7] | 4,299,679 [derived, p.7] |
| occupancy (Statement of activities) | 688,474 [derived, p.7] | 1,006,098 [derived, p.7] | 1,149,094 [derived, p.7] |
| depreciation and amortization (Statement of activities) | 1,502,109 [derived, p.7] | 1,166,736 [derived, p.7] | 1,213,765 [derived, p.7] |
| interest (Statement of activities) | 289,853 [derived, p.7] | 283,807 [derived, p.7] | 282,688 [derived, p.7] |
| other expenses (Statement of activities) | absent (not printed, or not read) | absent (not printed, or not read) | absent (not printed, or not read) |
| TOTAL EXPENSES (Statement of activities) | 31,435,032 [extracted, p.7] | 32,771,778 [extracted, p.7] | 33,975,257 [extracted, p.7] |
| OPERATING RESULT (Statement of activities) | -2,646,701 [extracted, p.7] | -2,019,710 [extracted, p.7] | -2,676,504 [extracted, p.7] |
| non-operating and other changes (Statement of activities) | 956,088 [derived, p.7] | 780,132 [derived, p.7] | 5,819,983 [derived, p.7] |
| CHANGE IN NET ASSETS (Statement of activities) | -1,690,613 [extracted, p.7] | -1,239,578 [extracted, p.7] | 3,143,479 [extracted, p.7] |
| net assets, beginning (Statement of activities) | 28,522,081 [extracted, p.7] | 29,761,659 [extracted, p.7] | 26,618,180 [extracted, p.7] |
| net assets, end (Statement of activities) | 26,831,468 [extracted, p.7] | 28,522,081 [extracted, p.7] | 29,761,659 [extracted, p.7] |

| Ratio | FY ending 2025-12-31 | FY ending 2024-12-31 | FY ending 2023-12-31 |
|---|---:|---:|---:|
| Days cash on hand | 171 days [plausible] | 183 days [plausible] | 179 days [plausible] |
| Current ratio | 7.56x [plausible] | 8.93x [plausible] | 7.37x [plausible] |
| Operating margin | -9.2% [plausible] | -6.6% [plausible] | -8.6% [plausible] |
| Total margin | -5.9% [plausible] | -4.0% [plausible] | 10.0% [plausible] |
| Patient revenue share | 62.5% [plausible] | 68.7% [plausible] | 57.5% [plausible] |
| Grant dependency | absent [not computed] | absent [not computed] | absent [not computed] |
| Salaries share | 66.7% [plausible] | 66.7% [plausible] | 64.6% [plausible] |
| Days in patient receivables | 40 days [plausible] | 26 days [plausible] | 40 days [plausible] |
| Debt to net assets | 0.20x [plausible] | 0.19x [plausible] | 0.20x [plausible] |
| Health center award share | absent [not computed] | absent [not computed] | absent [not computed] |

## Sources

HRSA Uniform Data System (awardee level; organization match Verified). CMS HCRIS cost reports, form CMS-224-14, as filed (the Medicare cost-report appendix). Federal Audit Clearinghouse single audits as filed (HEALTH FIRST BLUEGRASS; FAC-11 template snapshot, SRC-FAC-001); the organization match is matched by name.

Methodology: https://astrelis.co/methodology · Data sources: https://astrelis.co/data-sources · Data philosophy: https://astrelis.co/data-philosophy

## Cite this page

Astrelis Atlas, "Healthfirst Bluegrass Inc.", https://astrelis.co/providers/health_center/181812, release 2321a4fc37a7 (2026-10-22). Figures as filed in the named public sources; not audited by Astrelis.

Figures are as filed in the named public sources. Astrelis is not a CPA firm and performs no audit, review or attestation of any facility.